ArticleJournal of translational medicine2025

COL6A2 in clear cell renal cell carcinoma: a multifaceted driver of tumor progression, immune evasion, and drug sensitivity.

Yashuang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.